Arcadia wins FDA approval to sell oil byproduct, opening up big new market

Arcadia Biosciences Inc. said Tuesday it has won approval from the U.S. Food and Drug Administration to sell a byproduct of its genetically modified safflower product as livestock feed.

The approval opens up a potentially large market of cattle and poultry producers for the Davis-based food technology company. It also “improves the overall production economics of GLA safflower oil,” CEO Eric Rey said in a news release.

For years, the company has sold its genetically modified safflower oil as a human nutritional supplement. The company now can market a byproduct of that oil, safflower seed meal, to animal-feed manufacturers.

Read more